Exploring Hallucinogen Pharmacology and Psychedelic Medicine with Zebrafish Models
Zebrafish March 22, 2016 Evan J. Kyzar, Allan V. Kalueff 29 citations
After decades of sociopolitical obstacles, the field of psychiatry is experiencing a revived interest in the use of hallucinogenic agents to treat brain disorders. Along with the use of ketamine for depression, recent pilot studies have highlighted the efficacy of classic serotonergic hallucinogens, such as lysergic acid diethylamide and psilocybin, in treating addiction, post-traumatic stress...